Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Journal of Neurochemistry
|
March 10, 2001
Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways
A R White, X Huang, M F Jobling, et al.
The Journal of Membrane Biology
|
July 25, 2003
Copper modulation of ion channels of PrP[106-126] mutant prion peptide fragments
J I Kourie, B L Kenna, D Tew, et al.
The American Journal of Pathology
|
November 7, 1999
Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity
A R White, S J Collins, F Maher, et al.
Biochemistry
|
March 17, 1999
Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation
R Cappai, L Stewart, M F Jobling, et al.
Journal of Neuroscience Research
|
September 11, 2001
Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126
L R Stewart, A R White, M F Jobling, et al.
Neurobiology of Disease
|
April 13, 2001
Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons
A R White, R Guirguis, M W Brazier, et al.
Journal of Neurochemistry
|
September 29, 1999
The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126
M F Jobling, L R Stewart, A R White, et al.
Biochemistry
|
July 4, 2001
Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126
M F Jobling, X Huang, L R Stewart, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Journal of Neurochemistry
|
March 10, 2001
Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways
A R White, X Huang, M F Jobling, et al.
The Journal of Membrane Biology
|
July 25, 2003
Copper modulation of ion channels of PrP[106-126] mutant prion peptide fragments
J I Kourie, B L Kenna, D Tew, et al.
The American Journal of Pathology
|
November 7, 1999
Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity
A R White, S J Collins, F Maher, et al.
Biochemistry
|
March 17, 1999
Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation
R Cappai, L Stewart, M F Jobling, et al.
Journal of Neuroscience Research
|
September 11, 2001
Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126
L R Stewart, A R White, M F Jobling, et al.
Neurobiology of Disease
|
April 13, 2001
Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons
A R White, R Guirguis, M W Brazier, et al.
Journal of Neurochemistry
|
September 29, 1999
The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126
M F Jobling, L R Stewart, A R White, et al.
Biochemistry
|
July 4, 2001
Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126
M F Jobling, X Huang, L R Stewart, et al.
Page
of 1